Among cognitively unimpaired participants with a family history of dementia, changes in cognition and brain MRI outcomes from baseline to year 3 did not differ significantly between those who followed the MIND diet and those who followed the control diet with mild caloric restriction. 5 key findings →
Design: RCT
Participants: 604
Evidence: null result
Full summary, score breakdown and related studies →
Original source
Free full text
85/100
✓ Peer-reviewed
alzhub usefulness score 85 out of 100.
·
JAMA
·
2020-05-19
In this meta-analysis of randomized clinical trials, blood pressure lowering with antihypertensive agents compared with control was significantly associated with a lower risk of incident dementia or cognitive impairment. 4 key findings →
Design: meta-analysis
Participants: 96,158
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
Modifiable vascular and lifestyle-related risk factors have been associated with dementia risk in observational studies. 4 key findings →
Design: randomized controlled trial
Participants: 631
Evidence: high
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
These findings suggest that a hearing intervention might reduce cognitive change over 3 years in populations of older adults at increased risk for cognitive decline but not in populations at decreased risk for cognitive decline. 5 key findings →
Design: randomized controlled trial
Participants: 858
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
83/100
✓ Peer-reviewed
alzhub usefulness score 83 out of 100.
·
Nutrients
·
2025-08-04
Significant study-site, specimen type, and batch effects were observed. 5 key findings →
Design: randomized controlled trial
Participants: 604
Evidence: high
Full summary, score breakdown and related studies →
Original source
Epidemiologic studies suggest that a Mediterranean diet, an antioxidant-rich cardioprotective dietary pattern, delays cognitive decline, but clinical trial evidence is lacking. 5 key findings →
Design: RCT
Participants: 447
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Free full text
82/100
✓ Peer-reviewed
alzhub usefulness score 82 out of 100.
·
Nature Medicine
·
2025-04-21
Dementia is a leading cause of death and disability worldwide. 3 key findings →
Design: RCT
Participants: 33,995
Evidence: high
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
82/100
✓ Peer-reviewed
alzhub usefulness score 82 out of 100.
·
JAMA
·
2015-08-01
Among sedentary older adults, a 24-month moderate-intensity physical activity program compared with a health education program did not result in improvements in global or domain-specific cognitive function. 5 key findings →
Participants: 818
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
The first single-stage individual patient data meta-analysis from randomized double-blind placebo-controlled clinical trials provides evidence to support benefits of antihypertensive treatment in late-mid and later life to lower the risk of dementia. 5 key findings →
Design: meta-analysis
Participants: 28,008
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
80/100
✓ Peer-reviewed
alzhub usefulness score 80 out of 100.
·
JAMA
·
2013-10-01
During the CEE plus MPA intervention phase, the numbers of CHD cases were 196 for CEE plus MPA vs 159 for placebo (hazard ratio [HR], 1.18; 95% CI, 0.95-1.45) and 206 vs 155, respectively, for invasive breast cancer (HR, 1.24; 95% CI, 1.01-1.53). 3 key findings →
Participants: 8,506
Evidence: low
Full summary, score breakdown and related studies →
Original source
Free full text
Median follow-up by intention to treat was 2.0 years. 2 key findings →
Participants: 1,180
Evidence: low
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
79/100
✓ Peer-reviewed
alzhub usefulness score 79 out of 100.
·
JAMA neurology
·
2018-04-01
The APOE ε4 carriers and noncarriers were not significantly different at baseline (except for serum cholesterol level). 5 key findings →
Participants: 1,260
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
An intervention with MedDiets enhanced with either EVOO or nuts appears to improve cognition compared with a low-fat diet. 5 key findings →
Participants: 522
Evidence: high
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
The hippocampus shrinks in late adulthood, leading to impaired memory and increased risk for dementia. 4 key findings →
Design: randomized controlled trial
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
During a mean follow-up of 3.9 years, dementia was documented in 193 (6.3%) of the 3051 randomized participants in the actively treated group and 217 (7.1%) of the 3054 randomized participants in the placebo group (relative risk reduction, 12% [95% confidence interval, -8% to 28%]; P =.2). 4 key findings →
Participants: 6,105
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
The FINGER intervention was beneficial regardless of participants' characteristics and can thus be implemented in a large elderly population at increased risk for dementia. 3 key findings →
Participants: 1,260
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
76/100
✓ Peer-reviewed
alzhub usefulness score 76 out of 100.
·
JAMA
·
2025-08-26
This randomized trial followed 2,111 older adults at risk for cognitive decline across 5 US sites for two years, comparing a highly structured lifestyle program (regular exercise, MIND diet, cognitive/social engagement, health coaching) against a lower-intensity, self-guided version of the same components. 4 key findings →
Design: RCT
Participants: 2,111
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
76/100
✓ Peer-reviewed
alzhub usefulness score 76 out of 100.
·
Neurology
·
2025-02-11
This long-term follow-up of the SPRINT randomized trial tested whether intensively lowering systolic blood pressure (to below 120, vs. the standard target of below 140) reduces the risk of thinking problems in adults 50+ with hypertension. 4 key findings →
Design: RCT
Participants: 9,361
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
75/100
✓ Peer-reviewed
alzhub usefulness score 75 out of 100.
·
JAMA
·
2025-08-01
Among older adults at risk of cognitive decline and dementia, a structured, higher-intensity intervention had a statistically significant greater benefit on global cognition compared with an unstructured, self-guided intervention. 5 key findings →
Participants: 1,056
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
74/100
✓ Peer-reviewed
alzhub usefulness score 74 out of 100.
·
The Lancet
·
2015-03-12
This Finnish randomized controlled trial was the first large study to show that a two-year program combining diet counseling, exercise, cognitive training, and monitoring of heart-health risk factors could help maintain or improve thinking skills in older adults at elevated dementia risk, compared with a control group who received only general health advice. 3 key findings →
Design: RCT
Participants: 1,260
Evidence: high
Full summary, score breakdown and related studies →
Original source
A long-term intervention with an EVOO-rich MedDiet resulted in a better cognitive function in comparison with a control diet. 4 key findings →
Design: randomized controlled trial
Participants: 285
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
73/100
✓ Peer-reviewed
alzhub usefulness score 73 out of 100.
·
The Lancet
·
2023-09-02
This randomized trial gave hearing aids plus counseling, or only general health education, to 977 older adults with untreated hearing loss, then tracked cognition for three years. 4 key findings →
Design: RCT
Participants: 977
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Five RCTs of the Mediterranean diet and cognition have been published to date. 5 key findings →
Design: meta-analysis
Participants: 1,888
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
72/100
✓ Peer-reviewed
alzhub usefulness score 72 out of 100.
·
The Lancet
·
2026-07-13
These findings extend the evidence base for multidomain lifestyle interventions to populations historically under-represented in dementia research, supporting their feasibility and scalability as strategies to reduce cognitive decline risk amid the rapidly growing burden of dementia in low-income and middle-income countries. 3 key findings →
Design: RCT
Participants: 1,065
Evidence: moderate
Full summary, score breakdown and related studies →
Original source
Full text may need a subscription
72/100
✓ Peer-reviewed
alzhub usefulness score 72 out of 100.
·
Nature Medicine
·
2025-04-03
African heritage diets are increasingly being replaced by Western-style dietary patterns because of urbanization, economic development, increased access to processed foods, globalization and changing social norms. 2 key findings →
Design: randomized controlled trial
Evidence: high
Full summary, score breakdown and related studies →
Original source
Free full text
How the 0–100 score works — and why some entries are capped
This is alzhub's own score. It is not an official metric, not an impact factor,
and no journal, publisher or ranking body endorses it. We built it so that a reader who is not a
scientist can tell a landmark trial from a conference abstract without having to already know the
difference. Every point comes from one of 20 components, all of them printed on the study itself,
so you can disagree with our arithmetic rather than having to trust the total.
- Journal tier up to 10 pts
- Journal's citation record up to 4 pts
- Study design up to 12 pts
- Strength of evidence up to 5 pts
- Peer-review validation up to 10 pts
- How recent up to 5 pts
- Sample size up to 4 pts
- Effect reported up to 3 pts
- Studied in people up to 3 pts
- Randomised / blinded up to 2 pts
- Times cited up to 7 pts
- Citations per year up to 5 pts
- Impact for its field and year up to 6 pts
- Cited by studies here up to 6 pts
- Still being cited up to 4 pts
- Senior author's track record up to 4 pts
- Institution's track record up to 3 pts
- Multi-centre collaboration up to 3 pts
- Indexed in PubMed up to 2 pts
- Free to read up to 2 pts
Journals are placed in ordered tiers, never given a numeric impact factor — we
could not verify current impact factors from a source we control, and an invented one would be
worse than none. Tier 1 is the top-tier general journals (NEJM, The Lancet, JAMA, Nature, Science,
Nature Medicine); tier 2 is the leading specialty journals; tier 3 is every other peer-reviewed
journal. A separate part scores how much the journal's own papers are cited, which tells the
tier-3 journals apart.
Two rules we don't bend. First, we never fill in a
missing value: if a record does not state a sample size or a design, that component scores
zero, and if we simply have no data for a part, such as a citation count, that part is left out and
the study is scored on the parts we could check. The study card says which. Second, anything that is not a peer-reviewed
article is capped at 16/100 and carries a warning chip — so a conference abstract or
a company press release can never outrank a peer-reviewed paper, no matter how good it looks.
We rank a rigorous null result — a good trial showing that something does not
work — above an early positive finding. Someone deciding whether to buy a supplement is served by
that, and the rigour is already counted by the design and journal components.
The score is computed from the published data alone and is
reproducible: the same file always yields the same numbers.
See the whole rubric drawn out →
— four charts covering all 27,380 studies: how the scores are spread and where the cap
bites, which of the 20 components the library is strong and weak on, which subjects rest on
stronger evidence, and what kinds of study each subject is actually built from.